A prognostic score in histological node negative breast cancer.

od Chevallier, B., Mosseri, V., Dauce, J. P., Bastit, P., Julien, J. P., Asselain, B.
Izdano 1990

Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials.

od Tierney, J. F., Mosseri, V., Stewart, L. A., Souhami, R. L., Parmar, M. K.
Izdano 1995

Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer.

od Scholl, S. M., Bascou, C. H., Mosseri, V., Olivares, R., Magdelenat, H., Dorval, T., Palangié, T., Validire, P., Pouillart, P., Stanley, E. R.
Izdano 1994

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients.

od Tartour, E., Dorval, T., Mosseri, V., Deneux, L., Mathiot, C., Brailly, H., Montero, F., Joyeux, I., Pouillart, P., Fridman, W. H.
Izdano 1994

Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy

od Chauveinc, L, Buthaud, X, Falcou, M C, Mosseri, V, De la Rochefordière, A, Pierga, J Y, Girodet, J, Salmon, R J
Izdano 2003

Visualisation of the left anterior descending coronary artery on CT images used for breast radiotherapy planning

od Vennarini, S, Fournier-Bidoz, N, Aristei, C, de Almeida, C E, Servois, V, Campana, F, Mosseri, V, Fourquet, A, Kirova, Y M
Izdano 2013

Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy

od Rubie, H, Coze, C, Plantaz, D, Munzer, C, Defachelles, A S, Bergeron, C, Thomas, C, Chastagner, P, Valteau-Couanet, D, Michon, J, Mosseri, V, Hartmann, O
Izdano 2003

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification

od Schleiermacher, G, Michon, J, Huon, I, d'Enghien, C Dubois, Klijanienko, J, Brisse, H, Ribeiro, A, Mosseri, V, Rubie, H, Munzer, C, Thomas, C, Valteau-Couanet, D, Auvrignon, A, Plantaz, D, Delattre, O, Couturier, J
Izdano 2007

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group

od De Bernardi, B, Mosseri, V, Rubie, H, Castel, V, Foot, A, Ladenstein, R, Laureys, G, Beck-Popovic, M, de Lacerda, A F, Pearson, A D J, De Kraker, J, Ambros, P F, de Rycke, Y, Conte, M, Bruzzi, P, Michon, J
Izdano 2008

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project

od Schleiermacher, G, Mosseri, V, London, W B, Maris, J M, Brodeur, G M, Attiyeh, E, Haber, M, Khan, J, Nakagawara, A, Speleman, F, Noguera, R, Tonini, G P, Fischer, M, Ambros, I, Monclair, T, Matthay, K K, Ambros, P, Cohn, S L, Pearson, A D J
Izdano 2012

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative stud...

od Schleiermacher, G, Michon, J, Ribeiro, A, Pierron, G, Mosseri, V, Rubie, H, Munzer, C, Bénard, J, Auger, N, Combaret, V, Janoueix-Lerosey, I, Pearson, A, Tweddle, D A, Bown, N, Gerrard, M, Wheeler, K, Noguera, R, Villamon, E, Cañete, A, Castel, V, Marques, B, de Lacerda, A, Tonini, G P, Mazzocco, K, Defferrari, R, de Bernardi, B, di Cataldo, A, van Roy, N, Brichard, B, Ladenstein, R, Ambros, I, Ambros, P, Beiske, K, Delattre, O, Couturier, J
Izdano 2011